8-K: CalciMedica Expands Board, Director to Retire
Director Appointment and Retirement
CalciMedica, Inc. announced an expansion of its Board of Directors with the appointment of Dr. Evgeny Zaytsev and the upcoming retirement of director Fred Middleton.
Summary
- CalciMedica, Inc. has increased its Board of Directors from seven to eight members.
- Dr. Evgeny Zaytsev has been appointed as a Class I director, effective immediately, with his term expiring at the 2027 annual meeting of stockholders.
- Dr. Zaytsev will receive an annual cash retainer of $40,000 and was granted an option to purchase 20,000 shares of common stock, vesting over three years.
- Fred Middleton has informed the Board of his intention to retire at the Company's 2026 annual meeting of stockholders.
- Upon Mr. Middleton's retirement, the Board size will decrease back to seven directors.
- Mr. Middleton's retirement is not due to any disagreements with the Company.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting routine corporate governance changes without significant financial or strategic implications.
Positives
- Board expansion with the appointment of Dr. Evgeny Zaytsev, bringing potentially new expertise.
- Granting of stock options to Dr. Zaytsev aligns his interests with shareholders through a three-year vesting schedule.
- Fred Middleton's retirement is amicable and not a result of any disputes, indicating stable governance.
Negatives
- The board size will temporarily increase and then decrease, which could be seen as a minor administrative adjustment.
Risks
- There is no explicit mention of new risks in this filing. The appointment of a new director and the retirement of an existing one are standard corporate governance events.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding the company's financial performance or strategic direction. It focuses solely on changes in board composition.
Management Comments
- Fred Middleton informed the Board of his intention to retire from the Board effective on the Company's 2026 annual meeting of the stockholders.
- Mr. Middleton's retirement is not the result of any disagreement with the Company on any matter relating to its operations, policies, practices or otherwise.
Industry Context
StockSavvy.ai notes that board refreshment and the addition of specialized expertise, as seen with Dr. Zaytsev's appointment, are common strategies in the biotechnology sector to enhance strategic oversight and governance, especially for companies navigating complex research and development pathways.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | N/A | Evgeny Zaytsev, M.D., Ph.D. | July 2, 2026 | Board expansion and appointment to Class I director. |
| Director | Fred Middleton | N/A | 2026 annual meeting of stockholders | Retirement. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Size Adjustment | The size of the Board of Directors was increased from seven to eight directors. | July 2, 2026 | Minor administrative change to accommodate new director appointment. |
| Board Size Adjustment | The size of the Board of Directors will be decreased to seven directors upon Fred Middleton's retirement. | 2026 annual meeting of stockholders | Reversion to previous board size following director departure. |
Stakeholder Impact
- Shareholders: The appointment of a new director may bring fresh perspectives to the board. The stock option grant to the new director aligns their interests with shareholders over the long term.
- Employees: No direct impact mentioned.
- Creditors: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Customers: No direct impact mentioned.
Next Steps
- Fred Middleton will retire from the Board at the 2026 annual meeting of stockholders.
- The Board size will decrease to seven directors upon Mr. Middleton's retirement.
Key Dates
| Date | Description |
|---|---|
| September 4, 2020 | Filing date of CalciMedica's Registration Statement on Form S-1, which includes the standard form of Indemnity Agreement for directors. |
| July 2, 2026 | Effective date of Dr. Evgeny Zaytsev's appointment to the Board of Directors and the increase in Board size. Also the start date for the vesting of Dr. Zaytsev's stock options. |
| 2026 | Year of the Company's annual meeting of stockholders, at which Fred Middleton intends to retire. |
| 2027 | Year of the annual meeting of stockholders at which Dr. Evgeny Zaytsev's term of office is set to expire. |
| July 7, 2026 | Date the Form 8-K was signed. |
Keywords
CalciMedica, Board of Directors, Director Appointment, Director Retirement, Corporate Governance, Stock Options, SEC Filing, Form 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.